Wright Medical Group NV (NASDAQ:WMGI)’s share price reached a new 52-week high on Monday . The stock traded as high as $31.00 and last traded at $30.70, with a volume of 93889 shares traded. The stock had previously closed at $30.36.

Several equities analysts have recently weighed in on WMGI shares. BidaskClub upgraded shares of Wright Medical Group from a “hold” rating to a “buy” rating in a research note on Friday, October 19th. Needham & Company LLC boosted their price objective on shares of Wright Medical Group from $30.00 to $35.00 and gave the company a “buy” rating in a research note on Thursday, October 25th. Oppenheimer set a $30.00 price objective on shares of Wright Medical Group and gave the company a “hold” rating in a research note on Thursday, November 8th. Wells Fargo & Co boosted their price objective on shares of Wright Medical Group from $30.00 to $32.00 and gave the company an “outperform” rating in a research note on Thursday, November 8th. Finally, Piper Jaffray Companies boosted their price objective on shares of Wright Medical Group to $35.00 and gave the company an “overweight” rating in a research note on Thursday, November 8th. Two analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Wright Medical Group currently has a consensus rating of “Buy” and an average price target of $32.64.

The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.07 and a current ratio of 1.24. The firm has a market cap of $3.80 billion, a P/E ratio of -139.09, a price-to-earnings-growth ratio of 12.13 and a beta of 1.03.

In related news, Director Kevin C. Oboyle sold 17,277 shares of the stock in a transaction on Tuesday, November 13th. The shares were sold at an average price of $30.11, for a total transaction of $520,210.47. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Elizabeth H. Weatherman sold 15,949 shares of the stock in a transaction on Monday, November 19th. The shares were sold at an average price of $28.63, for a total transaction of $456,619.87. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 74,949 shares of company stock worth $2,209,064. 4.00% of the stock is owned by insiders.

A number of institutional investors have recently made changes to their positions in WMGI. FMR LLC grew its holdings in Wright Medical Group by 17.9% in the 3rd quarter. FMR LLC now owns 18,741,152 shares of the medical device company’s stock worth $543,869,000 after acquiring an additional 2,845,681 shares during the last quarter. Vanguard Group Inc. grew its holdings in Wright Medical Group by 25.8% in the 3rd quarter. Vanguard Group Inc. now owns 11,553,595 shares of the medical device company’s stock worth $317,015,000 after acquiring an additional 2,370,590 shares during the last quarter. Redmile Group LLC bought a new stake in Wright Medical Group in the 3rd quarter worth $63,081,000. Marshall Wace LLP grew its holdings in Wright Medical Group by 15,348.8% in the 3rd quarter. Marshall Wace LLP now owns 1,768,579 shares of the medical device company’s stock worth $51,324,000 after acquiring an additional 1,757,131 shares during the last quarter. Finally, Vanguard Group Inc grew its holdings in Wright Medical Group by 18.6% in the 3rd quarter. Vanguard Group Inc now owns 10,891,023 shares of the medical device company’s stock worth $316,058,000 after acquiring an additional 1,708,018 shares during the last quarter.

COPYRIGHT VIOLATION WARNING: “Wright Medical Group (WMGI) Hits New 52-Week High at $31.00” was posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this piece on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark legislation. The legal version of this piece can be viewed at https://theolympiareport.com/2019/02/11/wright-medical-group-wmgi-hits-new-52-week-high-at-31-00.html.

About Wright Medical Group (NASDAQ:WMGI)

Wright Medical Group NV operates as a global medical device company, which engages in the design, manufacture, and distribution of biologic products. It provides surgical solutions for the foot and ankle market and its products include large joint implants for the hip and knee, extremity implants for the shoulder, elbow, hand, wrist and foot and biologic products, including bone graft substitutes.

Read More: Is a Roth IRA right for you?

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.